K. Zarubina

BCR/ABL, IKZF deletions and FLT3-ITD as the targets for relapsed/refractory B-cell acute lymphoblastic leukemia treatment: Blinatumomab combined with Tyrosine kinase inhibitors and ATRA

E. Parovichnikova, O. Gavrilina, S. Bondarenko, 2020 .

SrPb 3 Br 8 :Pr crystals: growth and investigation of spectroscopic characteristics

L. Isaenko, A. Yelisseyev, A. Goloshumova, 2018 .